The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public–private collaboration aiming to develop and test a system for rapid vaccine benefit-risk monitoring using existing European healthcare databases. Incidence rate (IR) estimates of vaccination-associated adverse events that are needed to model vaccination risks can be calculated from existing healthcare databases when vaccination (exposure) data are available. We assessed different methods to derive IRs in risk periods following vaccination when exposure data are missing in one database, using estimated IRs and IRRs from other databases for febrile seizures, fever and persistent crying. IRs were estimated for children aged 0–5 years in outcome-sp...
Introduction: The public-private ADVANCE consortium (Accelerated development of vaccine benefit-risk...
Background: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is...
Usefulness of Vaccine-Adverse Event-Reporting System (VAERS) data and protocols required for statist...
The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public–pr...
The Accelerated Development of VAccine benefit-risk Collaboration in Europe (ADVANCE), a public-priv...
INTRODUCTION:The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) i...
INTRODUCTION: The public-private ADVANCE consortium (Accelerated development of vaccine benefit-risk...
Introduction The public-private ADVANCE consortium (Accelerated development of vaccine benefit-risk ...
INTRODUCTION: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) ...
IntroductionThe Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is...
Background: In May 2020, the ACCESS (The vACCine covid-19 monitoring readinESS) project was launched...
The Accelerated Development of VAccine benefit-risk Collaboration in Europe (ADVANCE), a public-priv...
Background: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is...
Introduction The public–private ADVANCE collaboration developed and tested a system to generate evid...
Introduction: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) ...
Introduction: The public-private ADVANCE consortium (Accelerated development of vaccine benefit-risk...
Background: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is...
Usefulness of Vaccine-Adverse Event-Reporting System (VAERS) data and protocols required for statist...
The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is a public–pr...
The Accelerated Development of VAccine benefit-risk Collaboration in Europe (ADVANCE), a public-priv...
INTRODUCTION:The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) i...
INTRODUCTION: The public-private ADVANCE consortium (Accelerated development of vaccine benefit-risk...
Introduction The public-private ADVANCE consortium (Accelerated development of vaccine benefit-risk ...
INTRODUCTION: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) ...
IntroductionThe Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is...
Background: In May 2020, the ACCESS (The vACCine covid-19 monitoring readinESS) project was launched...
The Accelerated Development of VAccine benefit-risk Collaboration in Europe (ADVANCE), a public-priv...
Background: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is...
Introduction The public–private ADVANCE collaboration developed and tested a system to generate evid...
Introduction: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) ...
Introduction: The public-private ADVANCE consortium (Accelerated development of vaccine benefit-risk...
Background: The Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) is...
Usefulness of Vaccine-Adverse Event-Reporting System (VAERS) data and protocols required for statist...